Think of Etelcalcetide as an IV Alternative to Cinacalcet

You'll see a new "calcimimetic," etelcalcetide (Parsabiv, PAR-sah-biv), for treating hyperparathyroidism in dialysis patients.

This condition is a vicious cycle.

Kidney failure leads to high phosphorous...which binds calcium. Low calcium triggers parathyroid hormone release...which boosts calcium, such as by pulling it from the GI tract and bones into blood. Phosphorous keeps binding calcium...which continues to trigger parathyroid hormone release.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals